Caveolin-1 expression is associated with high-grade bladder cancer

scientific article published on 01 November 2001

Caveolin-1 expression is associated with high-grade bladder cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0090-4295(01)01337-1
P698PubMed publication ID11711373

P2093author name stringS Garg
J K Mellon
G C Durkan
R Charlton
M C Robinson
P H Rajjayabun
P2860cites workCell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivoQ24324547
Molecular genetics of the caveolin gene family: implications for human cancers, diabetes, Alzheimer disease, and muscular dystrophyQ24539692
Caveolae, plasma membrane microdomains for alpha-secretase-mediated processing of the amyloid precursor proteinQ28268402
Genes encoding human caveolin-1 and -2 are co-localized to the D7S522 locus (7q31.1), a known fragile site (FRA7G) that is frequently deleted in human cancersQ28287729
Evidence for a regulated interaction between heterotrimeric G proteins and caveolinQ28304271
Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteinsQ28585091
Metastasis-related genes in prostate cancer: the role of caveolin-1.Q33715218
A detergent-free method for purifying caveolae membrane from tissue culture cellsQ33818572
Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinase cascadeQ33890028
The fine structure of the gall bladder epithelium of the mouse.Q34537858
Reduction of caveolin and caveolae in oncogenically transformed cellsQ34613343
A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signalingQ36293395
Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblastsQ37284379
Regulated migration of epidermal growth factor receptor from caveolaeQ40923075
Caveolae and caveolinsQ41099734
Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growthQ42440094
Cell biologists explore 'tiny caves'.Q47340307
Epidermal Growth Factor-stimulated Tyrosine Phosphorylation of Caveolin-1Q57371816
Original Articles: Bladder Cancer: Long-Term Outcome Related to Epidermal Growth Factor Receptor Status in Bladder CancerQ63966066
Tumor cell growth inhibition by caveolin re-expression in human breast cancer cellsQ74392346
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectbladder cancerQ504775
P304page(s)811-814
P577publication date2001-11-01
P1433published inUrologyQ7900884
P1476titleCaveolin-1 expression is associated with high-grade bladder cancer
P478volume58

Reverse relations

cites work (P2860)
Q36343101Anoikis and survival connections in the tumor microenvironment: is there a role in prostate cancer metastasis?
Q33872530Association of caveolin-1 and -2 genetic variants and post-treatment serum caveolin-1 with prostate cancer risk and outcomes
Q38980899CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition
Q34010236Caveolae structure and function
Q35190153Caveolae: mining little caves for new cancer targets
Q40809878Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype.
Q38876688Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer
Q34986770Caveolin-1 maintains activated Akt in prostate cancer cells through scaffolding domain binding site interactions with and inhibition of serine/threonine protein phosphatases PP1 and PP2A.
Q36646357Caveolin-1 up-regulation during epithelial to mesenchymal transition is mediated by focal adhesion kinase
Q37894860Caveolins in rhabdomyosarcoma
Q35107630Cell-surface cathepsin B: Understanding its functional significance
Q37427390Clinical and translational implications of the caveolin gene family: lessons from mouse models and human genetic disorders
Q37123792Clinical implications of caveolins in malignancy and their potential as therapeutic targets
Q27324084Co-regulation of cell polarization and migration by caveolar proteins PTRF/Cavin-1 and caveolin-1
Q57351003Differential expression of caveolin-1 in renal neoplasms
Q36591920Divergent control of Cav-1 expression in non-cancerous Li-Fraumeni syndrome and human cancer cell lines
Q40430236Expression of caveolin-1 and its correlation with cisplatin sensitivity in oral squamous cell carcinoma
Q35191653Expression of caveolin-1 in gastrointestinal and extraintestinal cancers
Q53649339Expression of caveolin-1 is associated with poor prognosis of patients with squamous cell carcinoma of the lung
Q39332149Functional interaction of tumor suppressor DLC1 and caveolin-1 in cancer cells.
Q47146869Genetic variation at the microRNA binding site of CAV1 gene is associated with lung cancer susceptibility
Q44024860Genetic variations of CAV1 gene contribute to HCC risk: a case-control study
Q42818560H-Ras-driven tumoral maintenance is sustained through caveolin-1-dependent alterations in calcium signaling.
Q34417941Identification of a novel prostate cancer biomarker, caveolin-1: Implications and potential clinical benefit
Q54378110Identification of a three-gene expression signature of early recurrence in non-muscle-invasive urothelial cell carcinoma of the bladder.
Q36854227Impact of caveolin-1 expression on the prognosis of transitional cell carcinoma of the upper urinary tract.
Q34996719Interaction among Caveolin-1 genotypes (rs3807987/rs7804372), H. pylori infection, and risk of gastric cancer in a Chinese population
Q33654095Involvement of Caveolin-1 in repair of DNA damage through both homologous recombination and non-homologous end joining
Q34167953Knockdown of caveolin-1 by siRNA inhibits the transformation of mouse hepatoma H22 cells in vitro and in vivo
Q35597185Live-cell imaging of tumor proteolysis: impact of cellular and non-cellular microenvironment
Q40564571Long-chain saturated fatty acids induce annexin II translocation to detergent-resistant membranes
Q37436585MMTV promoter-regulated caveolin-1 overexpression yields defective parenchymal epithelia in multiple exocrine organs of transgenic mice
Q52585875Mice with cav-1 gene disruption have benign stromal lesions and compromised epithelial differentiation.
Q34773206Mutant K-ras regulates cathepsin B localization on the surface of human colorectal carcinoma cells
Q47822697Overexpression of caveolin-1 in hepatocellular carcinoma with metastasis and worse prognosis: correlation with vascular endothelial growth factor, microvessel density and unpaired artery.
Q33411962Phase II trial of combination nab-paclitaxel, carboplatin and gemcitabine in first line therapy of advanced urothelial carcinoma
Q34135178Polyisoprenylated methylated protein methyl esterase as a putative drug target for androgen-insensitive prostate cancer
Q36791086Primary extraosseous Ewing sarcoma of the lung in children
Q33763551Significance of talin in cancer progression and metastasis
Q30408466Src and caveolin-1 reciprocally regulate metastasis via a common downstream signaling pathway in bladder cancer
Q36404008The Importance of Caveolin-1 as Key-Regulator of Three-Dimensional Growth in Thyroid Cancer Cells Cultured under Real and Simulated Microgravity Conditions
Q36050987The emerging role of the PI3-K-Akt pathway in prostate cancer progression
Q41783109The interrelationships between Src, Cav-1 and RhoGD12 in transitional cell carcinoma of the bladder.
Q35163625The potential protective role of caveolin-1 in intestinal inflammation in TNBS-induced murine colitis
Q37542947The role of caveolin-1 in prostate cancer: clinical implications.
Q34838964Transcriptional repression of Caveolin-1 (CAV1) gene expression by GATA-6 in bladder smooth muscle hypertrophy in mice and human beings
Q38576718Urothelial carcinoma with squamous differentiation--the pathologists׳ perspective
Q35791300cDNA microarray analysis of macroregenerative and dysplastic nodules in end-stage hepatitis C virus-induced cirrhosis

Search more.